ArticleThe pharmacogenomics journal2018
A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials.
A Sebio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.